Half-year report · Q2
4480.TEDINET S100U80N
Period2024-01-01 → 2024-06-30
Filed2024-08-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 47
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥14.7bn | 2024-01-01 → 2024-06-30 | Cons. | Net sales |
| Revenue | ¥20.5bn | 2023-01-01 → 2023-12-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥10.7bn | 2023-01-01 → 2023-06-30 | Cons. | Net sales |
| Operating income | ¥2.3bn | 2024-01-01 → 2024-06-30 | Cons. | Operating income |
| Operating income | ¥2.4bn | 2023-01-01 → 2023-06-30 | Cons. | Operating income |
| Ordinary income | ¥3.2bn | 2024-01-01 → 2024-06-30 | Cons. | Ordinary income |
| Ordinary income | ¥3.8bn | 2023-01-01 → 2023-12-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥2.8bn | 2023-01-01 → 2023-06-30 | Cons. | Ordinary income |
| Profit before tax | ¥3.2bn | 2024-01-01 → 2024-06-30 | Cons. | Income before income taxes |
| Profit before tax | ¥2.8bn | 2023-01-01 → 2023-06-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥2.0bn | 2024-01-01 → 2024-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥2.6bn | 2023-01-01 → 2023-12-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥1.9bn | 2023-01-01 → 2023-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥2.1bn | 2024-01-01 → 2024-06-30 | Cons. | Profit loss |
| Net income | ¥1.9bn | 2023-01-01 → 2023-06-30 | Cons. | Profit loss |
| Total assets | ¥42.2bn | at 2024-06-30 | Cons. | Assets |
| Total assets | ¥25.4bn | at 2023-12-31 | Cons. | Assets |
| Total assets | ¥24.5bn | at 2023-06-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥22.6bn | at 2024-06-30 | Cons. | Liabilities |
| Total liabilities | ¥7.8bn | at 2023-12-31 | Cons. | Liabilities |
| Net assets / equity | ¥19.5bn | at 2024-06-30 | Cons. | Net assets |
| Net assets / equity | ¥17.6bn | at 2023-12-31 | Cons. | Net assets |
| Net assets / equity | ¥17.2bn | at 2023-06-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥20.9bn | at 2024-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥15.4bn | at 2023-12-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥20.9bn | at 2024-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥15.4bn | at 2023-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥15.9bn | at 2023-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥14.4bn | at 2022-12-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥2.5bn | 2024-01-01 → 2024-06-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥3.9bn | 2023-01-01 → 2023-12-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥2.8bn | 2023-01-01 → 2023-06-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥8.2bn | 2024-01-01 → 2024-06-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥1.7bn | 2023-01-01 → 2023-12-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥805m | 2023-01-01 → 2023-06-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥11.1bn | 2024-01-01 → 2024-06-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥1.2bn | 2023-01-01 → 2023-12-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥385m | 2023-01-01 → 2023-06-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥61.9 | 2024-01-01 → 2024-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥79.53 | 2023-01-01 → 2023-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥58.48 | 2023-01-01 → 2023-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥61.5 | 2024-01-01 → 2024-06-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥78.55 | 2023-01-01 → 2023-12-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥57.65 | 2023-01-01 → 2023-06-30 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 46.1% | at 2024-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 69.0% | at 2023-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 69.9% | at 2023-06-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 34
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2024-01-01 → 2024-06-30 | −¥2m |
| Reconciling Itemsreconciling | revenue intersegment | 2024-01-01 → 2024-06-30 | −¥2m |
| Reconciling Itemsreconciling | segment profit | 2024-01-01 → 2024-06-30 | −¥2.2bn |
| jpcrp040300-q2r_E33586-000Medical Platform Businessreportable segment | revenue | 2024-01-01 → 2024-06-30 | ¥3.5bn |
| jpcrp040300-q2r_E33586-000Medical Platform Businessreportable segment | revenue external | 2024-01-01 → 2024-06-30 | ¥3.5bn |
| jpcrp040300-q2r_E33586-000Medical Platform Businessreportable segment | segment profit | 2024-01-01 → 2024-06-30 | ¥30m |
| jpcrp040300-q2r_E33586-000New Business Development Servicesreportable segment | revenue | 2024-01-01 → 2024-06-30 | ¥331m |
| jpcrp040300-q2r_E33586-000New Business Development Servicesreportable segment | revenue external | 2024-01-01 → 2024-06-30 | ¥331m |
| jpcrp040300-q2r_E33586-000New Business Development Servicesreportable segment | segment profit | 2024-01-01 → 2024-06-30 | −¥119m |
| jpcrp040300-q2r_E33586-000Recruitment Platform Businessreportable segment | revenue | 2024-01-01 → 2024-06-30 | ¥10.9bn |
| jpcrp040300-q2r_E33586-000Recruitment Platform Businessreportable segment | revenue external | 2024-01-01 → 2024-06-30 | ¥10.9bn |
| jpcrp040300-q2r_E33586-000Recruitment Platform Businessreportable segment | revenue intersegment | 2024-01-01 → 2024-06-30 | ¥2m |
| jpcrp040300-q2r_E33586-000Recruitment Platform Businessreportable segment | segment profit | 2024-01-01 → 2024-06-30 | ¥4.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-01-01 → 2024-06-30 | ¥14.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-01-01 → 2024-06-30 | ¥14.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2024-01-01 → 2024-06-30 | ¥2m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-01-01 → 2024-06-30 | ¥4.5bn |
| Reconciling Itemsreconciling | revenue | 2023-01-01 → 2023-06-30 | −¥1m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-01-01 → 2023-06-30 | −¥1m |
| Reconciling Itemsreconciling | segment profit | 2023-01-01 → 2023-06-30 | −¥1.2bn |
| jpcrp040300-q2r_E33586-000Medical Platform Businessreportable segment | revenue | 2023-01-01 → 2023-06-30 | ¥2.9bn |
| jpcrp040300-q2r_E33586-000Medical Platform Businessreportable segment | revenue external | 2023-01-01 → 2023-06-30 | ¥2.9bn |
| jpcrp040300-q2r_E33586-000Medical Platform Businessreportable segment | segment profit | 2023-01-01 → 2023-06-30 | −¥38m |
| jpcrp040300-q2r_E33586-000New Business Development Servicesreportable segment | revenue | 2023-01-01 → 2023-06-30 | ¥178m |
| jpcrp040300-q2r_E33586-000New Business Development Servicesreportable segment | revenue external | 2023-01-01 → 2023-06-30 | ¥178m |
| jpcrp040300-q2r_E33586-000New Business Development Servicesreportable segment | segment profit | 2023-01-01 → 2023-06-30 | −¥121m |
| jpcrp040300-q2r_E33586-000Recruitment Platform Businessreportable segment | revenue | 2023-01-01 → 2023-06-30 | ¥7.7bn |
| jpcrp040300-q2r_E33586-000Recruitment Platform Businessreportable segment | revenue external | 2023-01-01 → 2023-06-30 | ¥7.7bn |
| jpcrp040300-q2r_E33586-000Recruitment Platform Businessreportable segment | revenue intersegment | 2023-01-01 → 2023-06-30 | ¥1m |
| jpcrp040300-q2r_E33586-000Recruitment Platform Businessreportable segment | segment profit | 2023-01-01 → 2023-06-30 | ¥3.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-01-01 → 2023-06-30 | ¥10.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-01-01 → 2023-06-30 | ¥10.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-01-01 → 2023-06-30 | ¥1m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-01-01 → 2023-06-30 | ¥3.6bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 526
| Item | Context | Value | Unit |
|---|---|---|---|
| Cash and cash equivalents | Prior1QuarterInstant | 15928000000 | JPY |
| Cash and cash equivalents | CurrentQuarterInstant | 20852000000 | JPY |
| Salaries and allowances sga | Prior1YTDDuration | 2123000000 | JPY |
| Salaries and allowances sga | CurrentYTDDuration | 2831000000 | JPY |
| Depreciation sga | Prior1YTDDuration | 83000000 | JPY |
| Depreciation sga | CurrentYTDDuration | 222000000 | JPY |
| Business consignment expenses sga | Prior1YTDDuration | 398000000 | JPY |
| Business consignment expenses sga | CurrentYTDDuration | 688000000 | JPY |
| Advertising expenses sga | Prior1YTDDuration | 267000000 | JPY |
| Advertising expenses sga | CurrentYTDDuration | 468000000 | JPY |
| Provision of allowance for doubtful accounts sga | Prior1YTDDuration | 6000000 | JPY |
| Provision of allowance for doubtful accounts sga | CurrentYTDDuration | 8000000 | JPY |
| Provision for others sga | Prior1YTDDuration | 133000000 | JPY |
| Provision for others sga | CurrentYTDDuration | 77000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E33586-000RecruitmentPlatformBusinessReportableSegmentMember | 7654000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E33586-000MedicalPlatformBusinessReportableSegmentMember | 2874000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E33586-000NewBusinessDevelopmentServicesReportableSegmentMember | 178000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 10707000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | Prior1YTDDuration | 10707000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E33586-000RecruitmentPlatformBusinessReportableSegmentMember | 1000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E33586-000MedicalPlatformBusinessReportableSegmentMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E33586-000NewBusinessDevelopmentServicesReportableSegmentMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 1000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_ReconcilingItemsMember | -1000000 | JPY |
| Transactions with other segments | Prior1YTDDuration | － | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E33586-000RecruitmentPlatformBusinessReportableSegmentMember | 7655000000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E33586-000MedicalPlatformBusinessReportableSegmentMember | 2874000000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E33586-000NewBusinessDevelopmentServicesReportableSegmentMember | 178000000 | JPY |
| Net sales | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 10709000000 | JPY |
| Net sales | Prior1YTDDuration_ReconcilingItemsMember | -1000000 | JPY |
| Net sales | Prior1YTDDuration | 10707000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E33586-000RecruitmentPlatformBusinessReportableSegmentMember | 3779000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E33586-000MedicalPlatformBusinessReportableSegmentMember | -38000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E33586-000NewBusinessDevelopmentServicesReportableSegmentMember | -121000000 | JPY |
| Operating income | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 3619000000 | JPY |
| Operating income | Prior1YTDDuration_ReconcilingItemsMember | -1198000000 | JPY |
| Operating income | Prior1YTDDuration | 2420000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E33586-000RecruitmentPlatformBusinessReportableSegmentMember | 10864000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E33586-000MedicalPlatformBusinessReportableSegmentMember | 3510000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E33586-000NewBusinessDevelopmentServicesReportableSegmentMember | 331000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 14706000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | CurrentYTDDuration | 14706000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q2r_E33586-000RecruitmentPlatformBusinessReportableSegmentMember | 2000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q2r_E33586-000MedicalPlatformBusinessReportableSegmentMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q2r_E33586-000NewBusinessDevelopmentServicesReportableSegmentMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 2000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_ReconcilingItemsMember | -2000000 | JPY |
| Transactions with other segments | CurrentYTDDuration | － | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |